The families who call Ultimate Care Rx about a letter in the mail are rarely asking about reimbursement policy. They want to know whether their mother will still get her medication next month.
Michal Voldiner's team fields those calls. The answer has always been yes, and the reassurance is real: orders keep arriving, deliveries keep running, the pharmacist keeps picking up after hours. The reason the question keeps coming is that the economics underneath long-term care pharmacy shifted in January 2026, and the industry's own count of what that shift could cost residents is the largest number anyone in the sector has put on paper.
Where the 80% Coverage Cliff Number Comes From
A survey fielded in December 2025 by the Senior Care Pharmacy Coalition and the American Society of Consultant Pharmacists found that 84% of responding long-term care pharmacies planned to reduce services or stop serving communities and regions outright, and that 78% planned to lay off staff. The coalition's projection from those responses: cuts on that scale could affect more than 80% of long-term care residents nationwide, roughly 1.6 million older adults.
Two caveats belong on that figure, and the trade groups are open about both. The survey was fielded by advocacy organizations making a case to Congress, and its respondents represent about 20% of the roughly 1,400 closed-door long-term care pharmacies in the country. What those respondents do cover is substantial: more than 800,000 residents, nearly 300,000 of them in rural communities. The 80% is a projection of exposure rather than a count of losses. It describes how much of the country's long-term care population sits downstream of a small, thinly capitalized set of pharmacies.
A Long-Term Care Pharmacy Has No Cushion to Absorb This
Closed-door pharmacies have no retail counter. There's no front-of-store business, no photo counter, no seasonal aisle to offset a bad month on drug margin, and the service obligations run in the other direction.
Federal minimum performance criteria for a network long-term care pharmacy include unit-of-use packaging, around-the-clock on-call pharmacist coverage, daily secure delivery, IV capacity when required, emergency starter kits, drug utilization review software, and management reporting back to each community, according to a Milliman analysis of the sector. Milliman put the cost of dispensing to a nursing home resident at roughly 25% above retail, and counted 1,282 closed-door long-term care pharmacies as of 2023, a rounding error next to the retail sector's 61,700-plus locations.
Most of that mandated work has never been paid for directly, and there is no diversified revenue to absorb it: about three-quarters of long-term care pharmacy revenue comes from a single federal drug benefit. Insurance carriers historically reimbursed more on brand-name drugs, and that margin quietly covered thin generic reimbursement along with the packaging, the reviews, the kits, and the after-hours coverage, per the coalition's account of the model. Federal drug-price negotiation took effect on Jan. 1, 2026 and lowered brand payment. Both halves of the result are true at once. Residents and the program that covers them come out ahead: KFF reports CMS estimates of about $6 billion in savings had the negotiated prices applied in 2023, plus $1.5 billion in beneficiary savings in 2026. The cross-subsidy that funded the delivery infrastructure disappeared at the same time, and nothing replaced it.
Timing compounds the arithmetic. Settlement on negotiated drugs runs at least seven days longer than standard prompt-pay terms, and in an analysis of independent and community pharmacies the National Community Pharmacists Association put the resulting gap at nearly $11,000 per week in cash flow and about $43,000 a year for the average store. Long-term care pharmacies absorb the same delay with a thinner cushion behind it. A pharmacy buys the drug at market price, dispenses it, and waits.
What Service Reduction Looks Like at the Bedside
"Reducing services" is a phrase that hides its consequences. The average nursing home resident takes about 13 medications a day, and the work that keeps 13 medications from turning into an adverse event is the work on the cut list: error-preventing packaging, monthly review of the full regimen, maintained emergency kits, after-hours coverage, and medication reconciliation when a resident comes back from the hospital, per a May 2026 review of the crisis circulated by the coalition.
Trim any one of those and the loss lands on a specific evening. Fewer daily deliveries means a new order waits until tomorrow. Thinner after-hours coverage means a nurse with a question at 10 p.m. leaves a message. Less consultant-pharmacist time means a regimen gets reviewed to the letter of the requirement instead of to the point of catching something. None of it registers as a headline. All of it shows up in hospital transfers eventually.
How Michal Voldiner Reads the Squeeze From Inside a Los Angeles Pharmacy
Michal Voldiner has watched the pressure build from the operator's seat since founding Ultimate Care Rx in 2022. Some medications, depending on the insurance carrier, get dispensed at a loss.
Much of the work of keeping residents covered, by her account of building the pharmacy, has gone into insurance and billing surprises and the loopholes required to get around them. Her read on what sustained reimbursement pressure does to a pharmacy is unsentimental and mostly about people. She has watched the mechanism play out elsewhere in the industry: thin margins lead to thin staffing, workload climbs, and clinical errors follow the workload. That is the failure mode she manages against, and it is why she declines communities she cannot reach quickly rather than adding beds she would serve at a distance.
She states her standard the same way she did before any of this: do what's best for the resident, not what's easiest for the pharmacy. A reimbursement structure that pays for the pill and not for the pharmacist makes that standard expensive by design.
What Communities Should Ask a Long-Term Care Pharmacy Partner in 2026
For an administrator or clinical director evaluating continuity this year, the useful questions are operational.
How many deliveries a day, and until what hour? Who answers at 2 a.m., and is it a pharmacist? How much consultant-pharmacist time is contracted, and how is regimen review documented? Who maintains the emergency kit, and how fast is it replenished after a use? What notice applies before a fee change or a service reduction, and what happens to residents if the pharmacy exits the region?
A bipartisan fix has been proposed. The Preserving Patient Access to Long-Term Care Pharmacies Act, H.R. 5031 and S. 3159, would create a temporary per-prescription supply fee for drugs subject to negotiated prices. Both versions remained in committee with no floor vote scheduled as of spring 2026, per the same review, which means the sector spent this year absorbing the change rather than adjusting to a remedy.
The families still call. Voldiner's answer hasn't changed, and for the residents she serves the whole question is whether the pharmacy on the other end of the line is still doing the work it was doing last year.
Copyright © 2026 California Business Journal. All Rights Reserved.
For California Business Journal Disclaimers, go to /terms-conditions/.